Camden Capital, LLC Bristol Myers Squibb CO Transaction History

Camden Capital, LLC

  • $896 Million
  • Q3 2024

A detailed history of Camden Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Camden Capital, LLC holds 150,365 shares of BMY stock, worth $8.69 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
150,365
Previous 47,775 214.74%
Holding current value
$8.69 Million
Previous $1.98 Million 292.19%
% of portfolio
0.87%
Previous 0.16%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $4.07 Million - $5.31 Million
102,590 Added 214.74%
150,365 $7.78 Million
Q2 2024

Aug 06, 2024
BUY
$40.25 - $52.99 $194,850 - $256,524
4,841 Added 11.28%
47,775 $1.98 Million
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $105,795 - $119,952
2,205 Added 5.41%
42,934 $2.33 Million
Q4 2023

Feb 05, 2024
BUY
$48.48 - $57.85 $708,098 - $844,957
14,606 Added 55.91%
40,729 $2.09 Million
Q3 2023

Nov 03, 2023
BUY
$57.89 - $64.73 $93,550 - $104,603
1,616 Added 6.59%
26,123 $1.52 Million
Q2 2023

Aug 09, 2023
SELL
$63.71 - $70.74 $701,765 - $779,201
-11,015 Reduced 31.01%
24,507 $1.57 Million
Q1 2023

May 11, 2023
SELL
$65.71 - $74.53 $5,782 - $6,558
-88 Reduced 0.25%
35,522 $2.46 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $300,695 - $356,066
-4,391 Reduced 10.98%
35,610 $2.56 Million
Q3 2022

Nov 08, 2022
BUY
$0.13 - $76.84 $538 - $318,040
4,139 Added 11.54%
40,001 $2.84 Million
Q2 2022

Aug 03, 2022
SELL
$72.62 - $79.98 $288,737 - $318,000
-3,976 Reduced 9.98%
35,862 $2.78 Million
Q1 2022

May 06, 2022
BUY
$61.48 - $73.72 $1.21 Million - $1.45 Million
19,702 Added 97.84%
39,838 $2.92 Million
Q4 2021

Feb 28, 2022
SELL
$53.63 - $62.52 $29,550 - $34,448
-551 Reduced 2.66%
20,136 $1.26 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $39,418 - $45,952
735 Added 3.68%
20,687 $1.29 Million
Q3 2021

Nov 03, 2021
BUY
$59.17 - $69.31 $630,929 - $739,052
10,663 Added 114.79%
19,952 $1.18 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $77,820 - $84,746
-1,257 Reduced 11.92%
9,289 $621,000
Q1 2021

May 10, 2021
SELL
$59.34 - $66.74 $7,595 - $8,542
-128 Reduced 1.2%
10,546 $666,000
Q4 2020

Feb 04, 2021
BUY
$57.74 - $65.43 $115,018 - $130,336
1,992 Added 22.94%
10,674 $662,000
Q3 2020

Oct 30, 2020
BUY
$57.43 - $63.64 $191,012 - $211,666
3,326 Added 62.1%
8,682 $523,000
Q2 2020

Aug 11, 2020
SELL
$54.82 - $64.09 $452,265 - $528,742
-8,250 Reduced 60.64%
5,356 $315,000
Q1 2020

Apr 13, 2020
SELL
$46.4 - $67.43 $3,851 - $5,596
-83 Reduced 0.61%
13,606 $758,000
Q4 2019

Feb 10, 2020
BUY
$49.21 - $64.19 $673,635 - $878,696
13,689 New
13,689 $879,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email